Clinical tolerance 2008.
Publication
, Journal Article
Kirk, AD
Published in: Transplantation
April 15, 2009
In 2008, three publications highlighted the transition of tolerance from experimental to experiential. These included the first study to both anticipate and reproducibly deliver human leukocyte antigen-disparate allograft survival without continuous immunosuppressive drug administration. The other two highlighted unique episodes of clinical tolerance. The results from these studies are summarized and discussed.
Duke Scholars
Published In
Transplantation
DOI
EISSN
1534-6080
Publication Date
April 15, 2009
Volume
87
Issue
7
Start / End Page
953 / 955
Location
United States
Related Subject Headings
- Transplantation Tolerance
- Transplantation Immunology
- Transplantation Chimera
- Surgery
- Immunosuppressive Agents
- Immune Tolerance
- Humans
- Graft Survival
- Graft Rejection
- Antibody Formation
Citation
APA
Chicago
ICMJE
MLA
NLM
Kirk, A. D. (2009). Clinical tolerance 2008. Transplantation, 87(7), 953–955. https://doi.org/10.1097/TP.0b013e31819d415e
Kirk, Allan D. “Clinical tolerance 2008.” Transplantation 87, no. 7 (April 15, 2009): 953–55. https://doi.org/10.1097/TP.0b013e31819d415e.
Kirk AD. Clinical tolerance 2008. Transplantation. 2009 Apr 15;87(7):953–5.
Kirk, Allan D. “Clinical tolerance 2008.” Transplantation, vol. 87, no. 7, Apr. 2009, pp. 953–55. Pubmed, doi:10.1097/TP.0b013e31819d415e.
Kirk AD. Clinical tolerance 2008. Transplantation. 2009 Apr 15;87(7):953–955.
Published In
Transplantation
DOI
EISSN
1534-6080
Publication Date
April 15, 2009
Volume
87
Issue
7
Start / End Page
953 / 955
Location
United States
Related Subject Headings
- Transplantation Tolerance
- Transplantation Immunology
- Transplantation Chimera
- Surgery
- Immunosuppressive Agents
- Immune Tolerance
- Humans
- Graft Survival
- Graft Rejection
- Antibody Formation